Clinical Trial Update: An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BW430C (lamotrigine) versus placebo for prevention of mood episodes in bipolar I disorder has completed. Results were posted in July 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-07-27